Decreased epidermal growth factor (EGF) associated with HMGB1 and increased hyperactivity in children with autism

Biomarker Insights

Volumn 8, Issue , 2013, Pages 35-41

  Rrusso, Anthony J ^a  

^a HARTWICK COLLEGE   (United States)

Author keywords

Autism; EGF; GABA; HMGB1; PDD; Symptom severity

Indexed keywords

4 AMINOBUTYRIC ACID; EPIDERMAL GROWTH FACTOR; GLUTAMATE DECARBOXYLASE 65; HIGH MOBILITY GROUP B1 PROTEIN; SCATTER FACTOR; UROKINASE; UROKINASE RECEPTOR;

ARTICLE; AUTISM; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPERACTIVITY; MOTOR PERFORMANCE; PERVASIVE DEVELOPMENTAL DISORDER NOT OTHERWISE SPECIFIED; SCHOOL CHILD; SYMPTOM;

EID: 84875989085     PISSN: 11772719     EISSN: None     Source Type: Journal    
DOI: 10.4137/BMI.S11270     Document Type: Article

References (31)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DMS-IV-TR). Washington, DC: American Psychiatric Association; 2000.
2. Nickl-Jockschat T, Michel TM. The role of neurotrophic factors in autism. Mol Psychiatry. 2011;16:478-90.
3. Heck DE, Laskin DL, Gardner CR, Laskin JD. Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem. 1992;267:21277-80.
4. Okunishi K, Dohi M, Nakagome K, etal. A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol. 2005;175:4745-53.
5. Vega JA, García-Suárez O, Hannestad J, Pérez-Pérez M, Germanà A. Neurotrophins and the immune system. J Anat. 2003;203:1-19.
6. Tabakman R, Lecht S, Sephanova S, Arien-Zakay H, Lazarovici P. Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury. Prog Brain Res. 2004;146:387-401.
7. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57:67-81.
8. Li X, Chauhan A, Sheikh AM, etal. Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009;207:111-6.
9. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2011;25:40-5.
10. Enstrom AM, Onore CE, Van de Water JA, Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun. 2010;24:64-71.
11. Xian CJ, Zhou XF. Roles of transforming growth factor-α and related molecules in the nervous system. Mol Neurobiol. 1999;20:157-83.
12. Işeri E, Güney E, Ceylan MF, etal. Increased serum levels of epidermal growth factor in children with autism. J Autism Dev Disord. 2011;41(2):237-41.
13. Pastore S, Mascia F. Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin. Expert Rev Dermatol. 2008;3:525-7.
14. Toyoda T, Nakamura K, Yamada K, etal. SNP analyses of growth factor genes EGF, TGFβ-1, and HGF reveal haplotypic association of EGF with autism. Biochem Biophys Res Commun. 2007;360:715-20.
15. Suzuki K, Hashimoto K, Iwata Y, etal. Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism. Biol Psychiatry. 2007;62:267-9.
16. Youn JH, Oh YJ, Kim ES, Choi JE, Shin JS. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes. J Immunol. 2008;180:5067-74.
17. Oh YJ, Youn JH, Ji Y, Lee SE, Lim KJ, Choi JE, Shin JS. HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism. J Immunol. 2009;182:5800-9.
18. Rauvala H, Rouhiainen A. Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. Biochim Biophys Acta. 2010;1799:164-70.
19. Maroso M, Balosso S, Ravizza T, etal. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med. 2010;16:413-9.
20. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7:31-40.
21. Craig CG, Tropepe V, Morshead CM, Reynolds BA, Weiss S, Van Der Kooy D. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci. 1996;16:2649-58.
22. Miettinen PJ, Berger JE, Meneses J, etal. Epithelial im-maturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 1993;376:337-41.
23. Farrell RJ. Epidermal growth factor for ulcerative colitis. N Engl J Med. 2003;349:395-7.
24. Ménard D, Tremblay E, Ferretti E, etal. Anti-inflammatory effects of epidermal growth factor on the immature human intestine. Physiol Genomics. 2012;44(4):268-80.
25. Russo AJ, Krigsman A, Jepson B, Wakefield A. Decreased serum hepatocyte growth factor (HGF) in autistic children with severe gastrointestinal disease. Biomark Insights. 2009;4:181-90.
26. Onore C, Van de Water J, Ashwood P. Decreased levels of EGF in plasma of children with autism spectrum disorder. Autism Res Treat. 2012;2012: 205-362.
27. Bae MH, Bissonette GB, Mars WM, etal. Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility. Exp Neurol. 2010;221:129-35.
28. Zachmann M, Tocci P, Nyhan WL. The occurrence of gamma-aminobutyric acid in human tissues other than brain. J Biol Chem. 1966;241:1355-8.
29. Akimoto M, Baba A, Ikeda-Matsuo Y, etal. Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus. Neuroscience. 2004;128:155-62.
30. Ascoli GA, Alonso-Nanclares L, Anderson SA, etal. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci. 2008;9:557-68.
31. Bhat R, Axtell R, Mitra A, etal. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A. 2010;107(6):2580-5.